An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

Clinical trial NCT07644832 · RECRUITING

Trial details

NCT number: NCT07644832
Sponsor: Shanghai RAAS Blood Products Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hemophilia A Hemophilia B Factor VII Deficiency

Start date: 2024-05-31
Primary completion: 2026-12-31
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.